T4090 ophthalmic solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T4090 ophthalmic solution, covering 2026-01-02 to 2026-01-02. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension [Phase 2]